Related Experiment Video
Updated: Jun 26, 2026
07:46
Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 15, 2010
The triad: erectile dysfunction--endothelial dysfunction--cardiovascular disease
Charalambos Vlachopoulos1, Nikolaos Ioakeimidis, Dimitrios Terentes-Printzios
1Cardiovascular Diseases and Sexual Health Unit, 1st Department of Cardiology, Athens Medical School, Greece. cvlachop@otenet.gr
Current Pharmaceutical Design
|January 9, 2009
Summary
Erectile dysfunction (ED) is an early sign of generalized vascular disease, including coronary artery disease. Addressing ED can improve endothelial function and reduce cardiovascular risk.
Area of Science:
- Cardiovascular Medicine
- Urology
- Vascular Biology
Background:
- Endothelial dysfunction is central to atherosclerotic cardiovascular disease and vasculogenic erectile dysfunction (ED).
- ED is prevalent in patients with coronary artery disease and signals generalized vascular disease.
- ED serves as an early clinical manifestation and independent risk factor for cardiovascular events.
Purpose of the Study:
- To review the pathophysiologic links between endothelial dysfunction, ED, and coronary artery disease.
- To discuss methodological aspects of assessing penile and systemic endothelial function.
- To explore clinical implications for ED diagnosis, cardiovascular risk assessment, and treatment.
Main Methods:
- Literature review focusing on pathophysiologic mechanisms and clinical correlations.
- Analysis of diagnostic and therapeutic strategies for ED and cardiovascular disease.
- Evaluation of endothelial function assessment techniques.
Main Results:
- Endothelial dysfunction underlies both ED and cardiovascular disease, linking them pathophysiologically.
- ED is a significant indicator of underlying vascular disease and future cardiovascular events.
- Treatments for ED, including lifestyle changes and medications, may improve endothelial function and cardiovascular health.
Conclusions:
- ED is a crucial barometer for cardiovascular health in men, offering a window for early vascular disease detection.
- Improving endothelial function through ED treatment can mitigate cardiovascular risk.
- Integrated management of ED and cardiovascular risk factors is essential for patient well-being.
Related Concept Videos
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
01:20Disorders of the Male Reproductive System
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:30Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...